Transformative Data in Cisplatin-Ineligible MIBC: Clinical Implications of Enfortumab Vedotin Plus Pembrolizumab
Transformative Data in Cisplatin-Ineligible MIBC: Clinical Implications of Enfortumab Vedotin Plus Pembrolizumab

Thomas Powles, MD, MBBS, MRCP, Rahul Gosain, MD, MBA, Rohit Gosain, MD

The Promise of Anktiva: Expert Insight on IL-15 Therapy in Cancer Care
The Promise of Anktiva: Expert Insight on IL-15 Therapy in Cancer Care

Patrick Soon-Shiong, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

Thomas Powles, MD, MBBS, MRCP